Curasight Future Growth

Future criteria checks 2/6

Curasight is forecast to grow revenue at 105.6% per annum.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth45.7%
Revenue growth rate105.6%
Future return on equityn/a
Analyst coverage

Low

Last updated26 Aug 2024

Recent future growth updates

No updates

Recent updates

Curasight (NGM:CURAS) Is Making Moderate Use Of Debt

Aug 29
Curasight (NGM:CURAS) Is Making Moderate Use Of Debt

Earnings and Revenue Growth Forecasts

NGM:CURAS - Analysts future estimates and past financials data (DKK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202666N/AN/AN/A1
12/31/202540N/AN/AN/A1
12/31/20247N/AN/AN/A1
9/30/2024N/A-32-38-38N/A
6/30/2024N/A-32-34-34N/A
3/31/2024N/A-29-32-32N/A
12/31/2023N/A-26-30-30N/A
9/30/2023N/A-27-28-28N/A
6/30/2023N/A-25-28-28N/A
3/31/2023N/A-19-19-19N/A
12/31/2022N/A-18-24-16N/A
9/30/2022N/A-15-24-15N/A
6/30/2022N/A-13-22-12N/A
3/31/2022N/A-11-20-10N/A
12/31/2021N/A-8-10-7N/A
9/30/2021N/A-7-14-9N/A
6/30/2021N/A-7-13-8N/A
3/31/2021N/A-6-12-7N/A
12/31/2020N/A-6-12-7N/A
12/31/2019N/A-1-2-1N/A
12/31/2015N/A-1N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if CURAS's forecast earnings growth is above the savings rate (1.2%).

Earnings vs Market: Insufficient data to determine if CURAS's earnings are forecast to grow faster than the Swedish market

High Growth Earnings: Insufficient data to determine if CURAS's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CURAS's revenue (105.6% per year) is forecast to grow faster than the Swedish market (0% per year).

High Growth Revenue: CURAS's revenue (105.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if CURAS's Return on Equity is forecast to be high in 3 years time


Discover growth companies